- Home
- MRNA vs ZTO Comparison
MRNA vs ZTO Comparison
Compare MRNA & ZTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- ZTO
- Stock Information
- Founded
- MRNA 2010
- ZTO 2002
- Country
- MRNA United States
- ZTO China
- Employees
- MRNA N/A
- ZTO N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- ZTO Advertising
- Sector
- MRNA Health Care
- ZTO Consumer Discretionary
- Exchange
- MRNA Nasdaq
- ZTO Nasdaq
- Market Cap
- MRNA 16.0B
- ZTO 15.0B
- IPO Year
- MRNA 2018
- ZTO 2016
- Fundamental
- Price
- MRNA $35.53
- ZTO $20.78
- Analyst Decision
- MRNA Hold
- ZTO Buy
- Analyst Count
- MRNA 20
- ZTO 4
- Target Price
- MRNA $59.65
- ZTO $26.38
- AVG Volume (30 Days)
- MRNA 13.6M
- ZTO 2.6M
- Earning Date
- MRNA 02-14-2025
- ZTO 03-18-2025
- Dividend Yield
- MRNA N/A
- ZTO 4.67%
- EPS Growth
- MRNA N/A
- ZTO N/A
- EPS
- MRNA N/A
- ZTO 1.49
- Revenue
- MRNA $3,236,000,000.00
- ZTO $5,984,810,313.00
- Revenue This Year
- MRNA N/A
- ZTO $14.32
- Revenue Next Year
- MRNA $21.39
- ZTO $10.13
- P/E Ratio
- MRNA N/A
- ZTO $13.93
- Revenue Growth
- MRNA N/A
- ZTO 11.44
- 52 Week Low
- MRNA $29.25
- ZTO $17.89
- 52 Week High
- MRNA $170.47
- ZTO $27.50
- Technical
- Relative Strength Index (RSI)
- MRNA 48.60
- ZTO 64.81
- Support Level
- MRNA $32.78
- ZTO $19.72
- Resistance Level
- MRNA $36.98
- ZTO $20.31
- Average True Range (ATR)
- MRNA 2.50
- ZTO 0.43
- MACD
- MRNA 0.30
- ZTO 0.19
- Stochastic Oscillator
- MRNA 66.81
- ZTO 84.56
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.